On Monday, Bicara Therapeutics Inc (NASDAQ: BCAX) opened higher 7.03% from the last session, before settling in for the closing price of $9.25. Price fluctuations for BCAX have ranged from $7.80 to $28.09 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 42.88% at the time writing. With a float of $32.77 million, this company’s outstanding shares have now reached $54.53 million.
The firm has a total of 55 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Bicara Therapeutics Inc (BCAX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Bicara Therapeutics Inc is 39.92%, while institutional ownership is 62.30%. The most recent insider transaction that took place on Mar 14 ’25, was worth 1,021,211. In this transaction Chief Legal Officer of this company sold 79,146 shares at a rate of $12.90, taking the stock ownership to the 0 shares. Before that another transaction happened on Mar 14 ’25, when Company’s Officer proposed sale 79,146 for $13.35, making the entire transaction worth $1,056,599.
Bicara Therapeutics Inc (BCAX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.88% per share during the next fiscal year.
Bicara Therapeutics Inc (NASDAQ: BCAX) Trading Performance Indicators
Check out the current performance indicators for Bicara Therapeutics Inc (BCAX). In the past quarter, the stock posted a quick ratio of 24.62.
Technical Analysis of Bicara Therapeutics Inc (BCAX)
Analysing the last 5-days average volume posted by the [Bicara Therapeutics Inc, BCAX], we can find that recorded value of 1.31 million was better than the volume posted last year of 0.61 million. As of the previous 9 days, the stock’s Stochastic %D was 21.71%. Additionally, its Average True Range was 1.62.
During the past 100 days, Bicara Therapeutics Inc’s (BCAX) raw stochastic average was set at 23.65%, which indicates a significant decrease from 26.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 231.85% in the past 14 days, which was higher than the 118.65% volatility it showed in the past 100 days.
Now, the first resistance to watch is $10.38. This is followed by the second major resistance level at $10.86. The third major resistance level sits at $11.40. If the price goes on to break the first support level at $9.36, it is likely to go to the next support level at $8.82. Now, if the price goes above the second support level, the third support stands at $8.35.
Bicara Therapeutics Inc (NASDAQ: BCAX) Key Stats
There are currently 54,536K shares outstanding in the company with a market cap of 539.91 million. Presently, the company’s annual sales total 0 K according to its annual income of -68,000 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -36,850 K.
